EQA Scheme
Contact
Virus Genome Detection - Human Papillomaviruses (HPV) (373)
Samples:
5 samples of 1.5 ml
Sample properties:
Lyophilised cell culture material or biopsy material
Additional Information:
Cooperation with:
Nationales Referenzzentrum für Papillom- und Polyomaviren, Institut für Virologie, Uniklinik Köln
Requirement for EQAS/PT according to Rili-BÄK
Parameters:
Differentiation of 'high risk' and 'low risk' types, and typing of 'high risk' HPV and 'low risk' HPV, Polymerase chain reaction (PCR), other nucleic acid amplification techniques (NAT) and hybridization for HPV DNA
Certificate Validity: 12 months
Not subject to Rili-BÄK
Parameters:
not applicable
Certificate Validity: not applicable
Shipping Information:
Shipping not cooled
Safety Information:
Process as patient sample material. The participating laboratory must be authorized to perform direct and/or indirect detection of pathogens.
Dates:
Registration deadline:
Sample shipment:
Closing Date:
| June (4) | Nov. (6) |
|---|---|
| 09.04.2027 | 03.09.2027 |
| 08.06.2027 | 02.11.2027 |
| 25.06.2027 | 19.11.2027 |
EQAS/PT Experts:
Dr. Steffi Silling
Nationales Referenzzentrum für Papillom- und Polyomaviren
Institut für Virologie Uniklinik Köln
Fürst-Pückler-Straße 56
50935 Köln
+49 221-47885811
steffi.silling@instand-ringversuch.de
Dr. rer. nat. Martin Kammel
Institut für Qualitätssicherung in der Virusdiagnostik - IQVD
Potsdamer Chaussee 80
14129 Berlin
+49 30 8105 4300
m.kammel@iqvd.de